Skip to main content

Sleep Disorders

5
Pipeline Programs
7
Companies
13
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
0
2
0
1
0
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Small Molecule
2100%
+ 9 programs with unclassified modality

Competitive Landscape

7 companies ranked by most advanced pipeline stage

Neurim Pharmaceuticals
Neurim PharmaceuticalsIsrael - Tel Aviv
1 program
1
Circadin 2/5/10 mgPhase 31 trial
Active Trials
NCT01906866Completed125Est. Mar 2018
ViiV Healthcare
ViiV HealthcareNC - Durham
4 programs
2
2
GW597599Phase 2
Prototype Nasal DilatorPhase 2
AtorvastatinPhase 1Small Molecule
SB-649868Phase 1
GSK
GSKLONDON, United Kingdom
2 programs
AtorvastatinPHASE_1Small Molecule1 trial
SB-649868PHASE_11 trial
Active Trials
NCT01299597Completed30Est. Feb 2010
NCT01030939Completed72Est. Jan 2010
City Therapeutics
City TherapeuticsMA - Cambridge
1 program
ElectroacupunctureN/A1 trial
Active Trials
NCT06755593CompletedEst. Dec 2024
Masimo
MasimoIRVINE, CA
1 program
Normal saline infusionN/A1 trial
Active Trials
NCT01342328Completed3Est. Nov 2018
Teva
TevaIsrael - Petach Tikva
1 program
armodafinilPHASE_41 trial
Active Trials
NCT00518986Completed249Est. Mar 2009
Sanofi
SanofiPARIS, France
1 program
zolpidemPHASE_45 trials
Active Trials
NCT01097382Completed30Est. Apr 2011
NCT01024192Completed135Est. Jul 2010
NCT00359229Completed115
+2 more trials

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Sanofizolpidem
Sanofizolpidem
Tevaarmodafinil
Sanofizolpidem
Sanofizolpidem
Sanofizolpidem
Sanofizolpidem
Neurim PharmaceuticalsCircadin 2/5/10 mg
Sanofizolpidem
GSKAtorvastatin
GSKSB-649868
City TherapeuticsElectroacupuncture
MasimoNormal saline infusion

Clinical Trials (13)

Total enrollment: 1,622 patients across 13 trials

Sleep Satisfaction and Psychomotor Performance of Adults

Start: Mar 2010Est. completion: Apr 201130 patients
Phase 4Completed

Efficacy and Safety Assessment of ZOlpidem (Stilnox CR) in Patients With Chronic insomNIA

Start: Nov 2009Est. completion: Jul 2010135 patients
Phase 4Completed
NCT00518986Tevaarmodafinil

Efficacy and Safety of Armodafinil for Adults With Excessive Sleepiness Obstructive Sleep Apnea/Hypopnea and Depression

Start: Oct 2007Est. completion: Mar 2009249 patients
Phase 4Completed

Stilnox Treatment in Elderly Patients With Insomnia

Start: Jul 2006115 patients
Phase 4Completed

Ambien CR For Treatment Of Insomnia Associated With Depression When Used Concomitantly With Lexapro

Start: Feb 2006372 patients
Phase 4Completed

STILDEP: Zolpidem in Depressive and Dysthimic Patients

Start: Jan 2005Est. completion: Jun 2006120 patients
Phase 4Completed

Insomnia and Daytime Function in Osteoarthritis

Start: Mar 2003Est. completion: Jun 2004170 patients
Phase 4Completed

Efficacy and Safety of Circadin® in the Treatment of Sleep Disturbances in Children With Neurodevelopment Disabilities

Start: Oct 2013Est. completion: Mar 2018125 patients
Phase 3Completed

Efficacy, Safety, and Tolerability of Ambien (Zolpidem) in the Treatment of Children Ages 6 to 17 With Attention Deficit Hyperactivity Disorder (ADHD)-Associated Insomnia

Start: Apr 2006Est. completion: Aug 2006201 patients
Phase 3Completed
NCT01299597GSKAtorvastatin

A Single-centre Open Label Study to Investigate the Effect of Repeat Doses of SB-649868 on the Pharmacokinetics of Simvastatin and Atorvastatin in Healthy Male Volunteers.

Start: Jan 2010Est. completion: Feb 201030 patients
Phase 1Completed

Study to Investigate Safety, Tolerability, Pharmacokinetics and Cardiac Function After Repeat Doses of SB-649868 in Healthy-volunteers

Start: Aug 2009Est. completion: Jan 201072 patients
Phase 1Completed

Effectiveness of Intravascular Laser Therapy on Sleep Quality in Patients With Chronic Low Back Pain: A Randomized Controlled Trial

Start: Apr 2024Est. completion: Dec 2024
N/ACompleted
NCT01342328MasimoNormal saline infusion

Providing "Good Sleep" for ICU Sedation

Start: May 2012Est. completion: Nov 20183 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 late-stage (Phase 3) programs, potential near-term approvals
7 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.